A detailed history of Connectus Wealth, LLC transactions in Novartis Ag stock. As of the latest transaction made, Connectus Wealth, LLC holds 2,646 shares of NVS stock, worth $272,643. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,646
Previous 11,045 76.04%
Holding current value
$272,643
Previous $1.12 Million 77.13%
% of portfolio
0.01%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$95.27 - $108.47 $800,172 - $911,039
-8,399 Reduced 76.04%
2,646 $255,000
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $774,975 - $852,834
8,399 Added 317.42%
11,045 $1.12 Million
Q3 2023

Nov 13, 2023

BUY
$94.73 - $105.13 $250,655 - $278,173
2,646 New
2,646 $269,000
Q2 2022

Aug 08, 2022

SELL
$80.52 - $93.75 $665,980 - $775,406
-8,271 Closed
0 $0
Q1 2022

May 06, 2022

SELL
$80.11 - $90.62 $429,389 - $485,723
-5,360 Reduced 39.32%
8,271 $727,000
Q4 2021

Feb 09, 2022

BUY
$79.7 - $88.13 $1.09 Million - $1.2 Million
13,631 New
13,631 $1.2 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Connectus Wealth, LLC Portfolio

Follow Connectus Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connectus Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Connectus Wealth, LLC with notifications on news.